176 related articles for article (PubMed ID: 26598536)
21. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.
Liu P; Sun YL; Du J; Hou XS; Meng H
Int J Gynecol Cancer; 2012 May; 22(4):586-92. PubMed ID: 22266931
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
23. EphA8 is a prognostic marker for epithelial ovarian cancer.
Liu X; Xu Y; Jin Q; Wang W; Zhang S; Wang X; Zhang Y; Xu X; Huang J
Oncotarget; 2016 Apr; 7(15):20801-9. PubMed ID: 26989075
[TBL] [Abstract][Full Text] [Related]
24. Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study.
Xie J; Terry KL; Poole EM; Wilson KM; Rosner BA; Willett WC; Vesper HW; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):653-60. PubMed ID: 23417989
[TBL] [Abstract][Full Text] [Related]
25. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
[TBL] [Abstract][Full Text] [Related]
26. Inverse relationship between dietary fiber intake and environmental exposure to acrylamide.
Gong H; Liao S
Environ Sci Pollut Res Int; 2023 Mar; 30(12):35326-35333. PubMed ID: 36527552
[TBL] [Abstract][Full Text] [Related]
27. Circulating prolactin levels and risk of epithelial ovarian cancer.
Clendenen TV; Arslan AA; Lokshin AE; Liu M; Lundin E; Koenig KL; Berrino F; Hallmans G; Idahl A; Krogh V; Lukanova A; Marrangoni A; Muti P; Nolen BM; Ohlson N; Shore RE; Sieri S; Zeleniuch-Jacquotte A
Cancer Causes Control; 2013 Apr; 24(4):741-8. PubMed ID: 23378139
[TBL] [Abstract][Full Text] [Related]
28. Association between acrylamide exposure and the odds of developmental disabilities in children: A cross-sectional study.
Meng F; Qi Y; Wu Y; He F
Front Public Health; 2022; 10():972368. PubMed ID: 36249258
[TBL] [Abstract][Full Text] [Related]
29. Association of acrylamide hemoglobin biomarkers with chronic obstructive pulmonary disease in the general population in the US: NHANES 2013-2016.
Liu S; Ben X; Liang H; Fei Q; Guo X; Weng X; Wu Y; Wen L; Wang R; Chen J; Jing C
Food Funct; 2021 Dec; 12(24):12765-12773. PubMed ID: 34851334
[No Abstract] [Full Text] [Related]
30. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
[TBL] [Abstract][Full Text] [Related]
31. Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors.
Nhokaew W; Kleebkaow P; Chaisuriya N; Kietpeerakool C
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1161-1169. PubMed ID: 31030490
[TBL] [Abstract][Full Text] [Related]
32. Anthropometric factors and ovarian cancer risk in the Malmö Diet and Cancer Study.
Brändstedt J; Nodin B; Manjer J; Jirström K
Cancer Epidemiol; 2011 Oct; 35(5):432-7. PubMed ID: 21288792
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans.
Vesper HW; Bernert JT; Ospina M; Meyers T; Ingham L; Smith A; Myers GL
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2471-8. PubMed ID: 18006939
[TBL] [Abstract][Full Text] [Related]
34. Association between Acrylamide Hemoglobin Adduct Levels and Depressive Symptoms in US Adults: NHANES 2013-2016.
Li Z; Sun J; Zhang D
J Agric Food Chem; 2021 Nov; 69(46):13762-13771. PubMed ID: 34751566
[TBL] [Abstract][Full Text] [Related]
35. Among 10 sociodemographic and lifestyle variables, smoking is strongly associated with biomarkers of acrylamide exposure in a representative sample of the U.S. Population.
Vesper HW; Sternberg MR; Frame T; Pfeiffer CM
J Nutr; 2013 Jun; 143(6):995S-1000S. PubMed ID: 23596166
[TBL] [Abstract][Full Text] [Related]
36. High-throughput, simultaneous quantitation of hemoglobin adducts of acrylamide, glycidamide, and ethylene oxide using UHPLC-MS/MS.
Yang M; Frame T; Tse C; Vesper HW
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():197-205. PubMed ID: 29684911
[TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.
Jung S; Allen N; Arslan AA; Baglietto L; Barricarte A; Brinton LA; Egleston BL; Falk RT; Fortner RT; Helzlsouer KJ; Gao Y; Idahl A; Kaaks R; Krogh V; Merritt MA; Lundin E; Onland-Moret NC; Rinaldi S; Schock H; Shu XO; Sluss PM; Staats PN; Sacerdote C; Travis RC; Tjønneland A; Trichopoulou A; Tworoger SS; Visvanathan K; Weiderpass E; Zeleniuch-Jacquotte A; Dorgan JF
Int J Cancer; 2018 Jan; 142(2):262-270. PubMed ID: 28921520
[TBL] [Abstract][Full Text] [Related]
38. Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study.
Olesen PT; Olsen A; Frandsen H; Frederiksen K; Overvad K; Tjønneland A
Int J Cancer; 2008 May; 122(9):2094-100. PubMed ID: 18183576
[TBL] [Abstract][Full Text] [Related]
39. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
[TBL] [Abstract][Full Text] [Related]
40. Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.
Brandt S; Samartzis EP; Zimmermann AK; Fink D; Moch H; Noske A; Dedes KJ
BMC Cancer; 2017 Jan; 17(1):44. PubMed ID: 28073364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
